Selected article for: "AMI PEI high dose and dose PEI group"

Author: Hu, Zhiqiang; Xing, Yaling; Qian, Yuanyu; Chen, Xiaojuan; Tu, Jian; Ren, Lening; Wang, Kai; Chen, Zhongbin
Title: Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist
  • Document date: 2012_10_26
  • ID: 6fp8nly0_14
    Snippet: Following animal ethics approval from the Experimental Animal Care and Ethics Committee of Beijing Institute of Radiation Medicine, 41 male C57BL/6J mice (7-8 weeks old, 19.86 ± 0.98 g) were purchased from the Experimental Animal Center, Beijing Institute of Radiation Medicine. Animals were handled in accordance with Experimental Animal Care and Ethics Committee guidelines and the Code of Practice for the Care and use of Animals for Scientific P.....
    Document: Following animal ethics approval from the Experimental Animal Care and Ethics Committee of Beijing Institute of Radiation Medicine, 41 male C57BL/6J mice (7-8 weeks old, 19.86 ± 0.98 g) were purchased from the Experimental Animal Center, Beijing Institute of Radiation Medicine. Animals were handled in accordance with Experimental Animal Care and Ethics Committee guidelines and the Code of Practice for the Care and use of Animals for Scientific Purposes. Animals were housed in a parasite-free environment. Bedding was changed twice a week, and food and water were provided ad libitum. Animals were allowed to acclimatize to new surroundings before the experiment began. According to our experimental design, the minimal number of animals required was used. Mice were randomly divided into four groups: IR mock group (saline 20 ml/kg, irradiation, n = 10), low dose PEI group (5 mg/kg of PEI, irradiation, n = 10), radiation protection positive control group (AMI, 150 mg/kg, irradiation, n = 10) and high dose PEI group (10 mg/kg of PEI, irradiation, n = 11).

    Search related documents:
    Co phrase search for related documents
    • ad libitum and experimental design: 1, 2
    • ad libitum and mock group: 1
    • control group and experimental design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • control group and group divide: 1, 2
    • control group and high dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • control group and minimal number: 1, 2
    • control group and mock group: 1, 2, 3
    • experimental design and high dose: 1, 2, 3
    • high dose and mock group: 1, 2, 3, 4, 5